rs13405869
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000448666.7(MOGS):c.2032C>T(p.Arg678Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00437 in 1,614,170 control chromosomes in the GnomAD database, including 275 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R678L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000448666.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOGS | NM_006302.3 | c.2032C>T | p.Arg678Trp | missense_variant | 4/4 | ENST00000448666.7 | NP_006293.2 | |
MOGS | NM_001146158.2 | c.1714C>T | p.Arg572Trp | missense_variant | 5/5 | NP_001139630.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOGS | ENST00000448666.7 | c.2032C>T | p.Arg678Trp | missense_variant | 4/4 | 1 | NM_006302.3 | ENSP00000410992 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0231 AC: 3516AN: 152176Hom.: 148 Cov.: 33
GnomAD3 exomes AF: 0.00587 AC: 1464AN: 249522Hom.: 66 AF XY: 0.00425 AC XY: 576AN XY: 135392
GnomAD4 exome AF: 0.00241 AC: 3523AN: 1461876Hom.: 127 Cov.: 31 AF XY: 0.00204 AC XY: 1483AN XY: 727240
GnomAD4 genome AF: 0.0232 AC: 3527AN: 152294Hom.: 148 Cov.: 33 AF XY: 0.0214 AC XY: 1594AN XY: 74474
ClinVar
Submissions by phenotype
MOGS-congenital disorder of glycosylation Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 22, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 12, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at